TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 84 filers reported holding TG THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,542,000 | +452.6% | 229,001 | +179.6% | 0.12% | +443.5% |
| Q3 2019 | $460,000 | -64.1% | 81,901 | -44.7% | 0.02% | -68.5% |
| Q2 2019 | $1,282,000 | -36.0% | 148,201 | -40.5% | 0.07% | -39.2% |
| Q1 2019 | $2,004,000 | +256.0% | 249,201 | +81.6% | 0.12% | +233.3% |
| Q4 2018 | $563,000 | +275.3% | 137,201 | +411.6% | 0.04% | +414.3% |
| Q3 2018 | $150,000 | -85.5% | 26,819 | -65.9% | 0.01% | -83.3% |
| Q2 2018 | $1,034,000 | +77.7% | 78,652 | +35.6% | 0.04% | +35.5% |
| Q2 2017 | $582,000 | +131.0% | 58,000 | +7.0% | 0.03% | +106.7% |
| Q4 2016 | $252,000 | -53.1% | 54,200 | -38.9% | 0.02% | -44.4% |
| Q2 2016 | $537,000 | +231.5% | 88,654 | +552.3% | 0.03% | +237.5% |
| Q4 2015 | $162,000 | +6.6% | 13,591 | -9.9% | 0.01% | +33.3% |
| Q3 2015 | $152,000 | -56.1% | 15,091 | -27.7% | 0.01% | -50.0% |
| Q2 2015 | $346,000 | -62.5% | 20,862 | -64.2% | 0.01% | -64.7% |
| Q4 2014 | $922,000 | +1198.6% | 58,245 | +308.2% | 0.03% | +750.0% |
| Q3 2013 | $71,000 | – | 14,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |